ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.469,46
-0,03%
S&P 500
5.165,39
0,73%
US Dollar vs BRL
5,0726
0,00%
Bitcoin
62.962,45
-1,62%
Brent Oil
83,255
0,16%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Achillion Pharmaceuticals Inc (ACHN)

  7. Achillion Pharmaceuticals Inc (ACHN) Notícias

ACHN

Achillion Pharmaceuticals (ACHN)

Achillion Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ACHN
DataHoraFonteTítuloCódigoCompanhia
14/02/202018:55Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACHNAchillion Pharmaceuticals Inc
14/02/202015:29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
07/02/202008:11Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:ACHNAchillion Pharmaceuticals Inc
03/02/202008:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACHNAchillion Pharmaceuticals Inc
19/12/201911:24GlobeNewswire Inc.Achillion Shareholders Approve Agreement to be Acquired by AlexionNASDAQ:ACHNAchillion Pharmaceuticals Inc
09/12/201912:00GlobeNewswire Inc.Achillion Reports Positive Data from Phase 2 Study of Danicopan (ACH-4471) in Combination with Eculizumab in PNH Patients who...NASDAQ:ACHNAchillion Pharmaceuticals Inc
22/11/201912:42PR Newswire (US)Moore Kuehn, PLLC Encourages Investors of SRC Energy, Inc. (SRCI), Achillion Pharmaceuticals, Inc. (ACHN), and Arotech Corpor...NASDAQ:ACHNAchillion Pharmaceuticals Inc
19/11/201909:30GlobeNewswire Inc.European Medicines Agency Grants PRIME Designation to Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients...NASDAQ:ACHNAchillion Pharmaceuticals Inc
11/11/201909:30GlobeNewswire Inc.Achillion Announces Clearance of Investigational New Drug Application for ACH-5228NASDAQ:ACHNAchillion Pharmaceuticals Inc
07/11/201918:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACHNAchillion Pharmaceuticals Inc
07/11/201918:18Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
07/11/201918:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACHNAchillion Pharmaceuticals Inc
07/11/201909:30GlobeNewswire Inc.Achillion Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:ACHNAchillion Pharmaceuticals Inc
06/11/201911:07GlobeNewswire Inc.Achillion Announces Data Presentations at the 61st American Society of Hematology Annual MeetingNASDAQ:ACHNAchillion Pharmaceuticals Inc
05/11/201919:07Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
01/11/201917:23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
18/10/201918:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACHNAchillion Pharmaceuticals Inc
18/10/201917:50PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Achillion Pharmaceuticals, Inc.NASDAQ:ACHNAchillion Pharmaceuticals Inc
16/10/201911:44PR Newswire (US)Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Achillion Pharmaceuticals, Inc. has obtained a Fair Price in it...NASDAQ:ACHNAchillion Pharmaceuticals Inc
16/10/201909:50PR Newswire (US)Achillion (ACHN) Alert: Johnson Fistel Investigates Proposed Sale of Achillion Pharmaceuticals; Are Shareholders Getting a Fa...NASDAQ:ACHNAchillion Pharmaceuticals Inc
16/10/201909:28Dow Jones NewsAchillion Pharmaceuticals Shares Up 84% on Buyout DealNASDAQ:ACHNAchillion Pharmaceuticals Inc
16/10/201908:24Dow Jones NewsAlexion Pharmaceuticals Buys Achillion Pharma for $930 MillionNASDAQ:ACHNAchillion Pharmaceuticals Inc
16/10/201907:30Business WireAlexion to Acquire AchillionNASDAQ:ACHNAchillion Pharmaceuticals Inc
26/09/201909:32GlobeNewswire Inc.Achillion to Present at the 2019 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:ACHNAchillion Pharmaceuticals Inc
25/09/201908:00GlobeNewswire Inc.Achillion Receives Breakthrough Therapy Designation from FDA for Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinur...NASDAQ:ACHNAchillion Pharmaceuticals Inc
29/08/201918:00GlobeNewswire Inc.Achillion to Present at the Baird 2019 Global Healthcare ConferenceNASDAQ:ACHNAchillion Pharmaceuticals Inc
08/08/201908:30GlobeNewswire Inc.Achillion Reports Second Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:ACHNAchillion Pharmaceuticals Inc
22/07/201908:00GlobeNewswire Inc.Achillion’s ACH-5228 Achieves Positive Results in Phase 1 Multiple Ascending Dose Study in Healthy VolunteersNASDAQ:ACHNAchillion Pharmaceuticals Inc
13/06/201908:00GlobeNewswire Inc.Achillion to Present at the JMP Securities Life Sciences ConferenceNASDAQ:ACHNAchillion Pharmaceuticals Inc
10/06/201908:00GlobeNewswire Inc.Achillion Announces Upcoming Scientific Presentation at the 24th Congress of the European Hematology AssociationNASDAQ:ACHNAchillion Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ACHN

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
AZEV4
AZEVEDO PN
BOV
LUPA3
LUPATECH ON
BOV
BRKM5
BRASKEM PNA
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
KRSA3
Kora Saude Participacoes... ON
BOV
TELB4
TELEBRAS PN
BOV
NGRD3
Neogrid Participacoes ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
PRIO3
PETRORIO ON
BOV
GOLL4
GOL PN
BOV
TPIS3
TRIUNFO PART ON
BOV
POMO4
MARCOPOLO PN
BOV
AZEV3
AZEVEDO ON
BOV
ETER3
ETERNIT ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados